[
    [
        {
            "time": "2023-10-01",
            "original_text": "巨头联姻！云南白药入股上药！",
            "features": {
                "keywords": [
                    "云南白药",
                    "上药",
                    "联姻",
                    "入股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "巨头联姻！云南白药入股上药！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-02",
            "original_text": "一项大规模多中心临床研究表明：“清肺排毒汤”可有效降低新冠肺炎死亡风险；知名药企 重磅大品种过评丨贝壳日报",
            "features": {
                "keywords": [
                    "清肺排毒汤",
                    "新冠",
                    "死亡风险",
                    "药企",
                    "过评"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一项大规模多中心临床研究表明：“清肺排毒汤”可有效降低新冠肺炎死亡风险；知名药企 重磅大品种过评丨贝壳日报",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-03",
            "original_text": "A股医药生物公司研发实力排行榜：恒瑞医药、复星医药、君实生物研发投入居前三，药明康德研发人员数量最多",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "复星医药",
                    "君实生物",
                    "药明康德",
                    "研发投入"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A股医药生物公司研发实力排行榜：恒瑞医药、复星医药、君实生物研发投入居前三，药明康德研发人员数量最多",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-04",
            "original_text": "强强联姻！云南白药斥资112亿入股上海医药",
            "features": {
                "keywords": [
                    "云南白药",
                    "上海医药",
                    "入股",
                    "112亿"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "强强联姻！云南白药斥资112亿入股上海医药",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "云南白药炒股浮亏 秘方“含金量”难比片仔癀 投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "浮亏",
                    "投资失误"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药炒股浮亏 秘方“含金量”难比片仔癀 投资失误",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "云南白药与上海医药、天津医药拟共建中医药产业联盟",
            "features": {
                "keywords": [
                    "云南白药",
                    "上海医药",
                    "天津医药",
                    "中医药产业联盟"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药与上海医药、天津医药拟共建中医药产业联盟",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "快讯 | 上海医药、云南白药及天津医药拟共建“中医药产业联盟”，上海医药引入云南白药作为战略投资者、天津医药完成混改后首次三方合作",
            "features": {
                "keywords": [
                    "上海医药",
                    "云南白药",
                    "天津医药",
                    "中医药产业联盟",
                    "战略投资者",
                    "混改"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "快讯 | 上海医药、云南白药及天津医药拟共建“中医药产业联盟”，上海医药引入云南白药作为战略投资者、天津医药完成混改后首次三方合作",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "瑞信：下调上海医药(2607.HK)目标价至20港元 评级“跑赢大市” 机构下调估值",
            "features": {
                "keywords": [
                    "瑞信",
                    "上海医药",
                    "目标价",
                    "下调",
                    "估值"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "瑞信：下调上海医药(2607.HK)目标价至20港元 评级“跑赢大市” 机构下调估值",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "医药生物行业事件点评：全方位推动中医药服务出口基地高质量发展",
            "features": {
                "keywords": [
                    "医药生物",
                    "中医药服务",
                    "出口基地",
                    "高质量发展"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业事件点评：全方位推动中医药服务出口基地高质量发展",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "云南白药112亿入股上海医药，刚亏了8亿的云南白药想干啥？ 亏损",
            "features": {
                "keywords": [
                    "云南白药",
                    "上海医药",
                    "入股",
                    "112亿",
                    "亏损"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药112亿入股上海医药，刚亏了8亿的云南白药想干啥？ 亏损",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]